Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer
about
Contralateral prophylactic mastectomy: current perspectivesUnremarked or Unperformed? Systematic Review on Reporting of Validation Efforts of Health Economic Decision Models in Seasonal Influenza and Early Breast CancerRisk of asynchronous contralateral breast cancer: multiple approaches for a complex issue.Cost of contralateral prophylactic mastectomyCost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patientsContralateral risk-reducing mastectomy: review of risk factors and risk-reducing strategies.Better contralateral breast cancer risk estimation and alternative options to contralateral prophylactic mastectomyContralateral prophylactic mastectomy after unilateral breast cancer: a systematic review and meta-analysisTrends and variation in use of breast reconstruction in patients with breast cancer undergoing mastectomy in the United StatesContralateral prophylactic mastectomy and its impact on quality of lifeContralateral Prophylactic Mastectomy Consensus Statement from the American Society of Breast Surgeons: Additional Considerations and a Framework for Shared Decision Making.Outcomes of contralateral prophylactic mastectomy in relation to familial history: a decision analysis (BRCR-D-16-00033).Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research.Trends and clinical implications of preoperative breast MRI in Medicare beneficiaries with breast cancer.Attitudes to contralateral risk reducing mastectomy among breast and plastic surgeons in England.Contralateral Prophylactic Mastectomy with Immediate Breast Reconstruction Increases Healthcare Utilization and Cost.The financial impact and drivers of hospital charges in contralateral prophylactic mastectomy and reconstruction: a Nationwide Inpatient Sample hospital analysis.Early breast cancer in the older woman.Benefits and risks of contralateral prophylactic mastectomy in women undergoing treatment for sporadic unilateral breast cancer: a decision analysis.Negative Genetic Testing Does Not Deter Contralateral Prophylactic Mastectomy in Younger Patients with Greater Family Histories of Breast Cancer.Donor-Site Morbidity After DIEAP Flap Breast Reconstruction-A 2-Year Postoperative Computed Tomography Comparison.Cost-effectiveness of contralateral prophylactic mastectomy for prevention of contralateral breast cancer.Prophylactic Surgery: For Whom, When and How?Cost-effectiveness Analysis of Contralateral Prophylactic Mastectomy Compared to Unilateral Mastectomy with Routine Surveillance for Unilateral, Sporadic Breast Cancer.Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review.Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer.Mastectomies of healthy, contralateral breasts in patients with breast cancer
P2860
Q26744320-C15600CC-4845-4069-B366-85991E39CD7DQ26748855-A50DF597-F312-41B1-BFAA-C12C999F1C99Q33972981-0938C6BA-31EB-44E8-914A-ADCCC4215F02Q34017128-81BE523B-B87D-47F0-8126-0E8EA4E8C7A6Q35008290-050B10C1-FB05-478F-8EBA-11993E7DBC21Q35066801-25B4A1E0-DBFE-48FB-96DE-EC0898FC430EQ35073191-5227F278-5137-4F14-91EA-934AEBB169E4Q35192288-4D6AED0E-9908-4DAE-A6DD-75DF3FCBB8E7Q36925041-45A41230-1780-48E5-AC08-519CD57C552EQ37147521-D5F2C70A-F2D6-4693-9413-7C6FDE7F5203Q37208201-399A3A9D-E94F-4553-9184-C06AE9FFA996Q37267678-27FBFB3E-218D-43CF-916E-D9E3C0CC3059Q37387444-B4AEC221-DC01-44B3-BA9D-60429EDE0349Q37483341-ADE6EC50-6B78-4695-B3C4-8D87C47539A7Q37556568-D2E9C5B8-8A7A-4817-B600-781425E02D11Q38647477-4F7C9CAF-6560-475A-B0ED-F37B0A747FACQ38716295-6F91D0FD-D1EC-4C91-B62F-E3A654C0C7EAQ39653595-3C416895-61FC-4606-8719-E92E8E0C8DC8Q40848631-DC7F901E-9FCC-48DD-AD34-6713EDFF92CDQ41088085-119B06A5-C38C-4F04-B4EE-703B92BBCD0AQ41306349-423157F6-C1E8-459C-93F0-2E7029FB86D6Q48082941-D1396A7A-C5AF-4EBC-A9DD-A543CD741E79Q49885181-BE1AC537-004B-4FB4-9967-C9FE69B26BA1Q50077911-C98E621D-99FB-4FF2-9AA9-F9B94D7D4308Q50091589-970920D7-FED5-4961-B89B-507B821516D8Q51346860-009672E0-59A7-44FB-B223-E90C01A506F0Q57266518-D84F0166-D06C-4291-A131-8235D3CC4368
P2860
Cost-effectiveness of contralateral prophylactic mastectomy versus routine surveillance in patients with unilateral breast cancer
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Cost-effectiveness of contrala ...... with unilateral breast cancer
@ast
Cost-effectiveness of contrala ...... with unilateral breast cancer
@en
type
label
Cost-effectiveness of contrala ...... with unilateral breast cancer
@ast
Cost-effectiveness of contrala ...... with unilateral breast cancer
@en
prefLabel
Cost-effectiveness of contrala ...... with unilateral breast cancer
@ast
Cost-effectiveness of contrala ...... with unilateral breast cancer
@en
P2093
P2860
P356
P1476
Cost-effectiveness of contrala ...... with unilateral breast cancer
@en
P2093
Amy C Degnim
David R Farley
Jamie O'Byrne
Judy C Boughey
P2860
P304
P356
10.1200/JCO.2011.35.6956
P407
P577
2011-06-20T00:00:00Z